Riskpilot← Back to searchSign inGet full accessAcipa AB
ABActiveOrg 5592801137Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20200 employees
Revenue 2025
SEK 0
EBITDA margin
—
-316% vs 2024
Equity ratio
44.7%
Financial strength
Net profit 2025
SEK -15K
-317% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -15K | -316% |
| Net profit | SEK -15K | -317% |
| Total assets | SEK 36K | +4% |
| Equity | SEK 16K | -39% |
| Employees | 0 | — |
Legal name
Acipa AB
Org number
5592801137
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
2 november 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva verksamhet inom labmedicin och diagnostik och därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 500 | 935 | 209 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | — | −28 | 6 | −4 | −15 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 0 | −28 | 6 | −4 | −15 |
| Net financials | — | — | — | — | −0 |
| Profit before tax | 0 | 0 | 6 | −4 | −15 |
| Tax | −0 | — | −1 | — | — |
| Net profit | 0 | 0 | 5 | −4 | −15 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 227 | 78 | 39 | 35 | 36 |
| Equity | 25 | 25 | 30 | 27 | 16 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 202 | 53 | 8 | 8 | 20 |
| Total debt | 202 | 53 | 8 | 8 | 20 |
EBITDA margin
-1537700.0%
This company
15.8%
Market median
-9732378% vs market
20212025
Equity ratio
44.7%
This company
38.2%
Market median
+17% vs market
20212025
Return on equity
-95.3%
This company
18.4%
Market median
-618% vs market
20212025
Net profit margin
-1541500.0%
This company
8.1%
Market median
-19030964% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
1.24×
This company
0.62×
Market median
-100% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-11-01 – 2021-08-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HM Audit | Audit | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Convilium AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Convilium AB
Acipa AB Board members of Acipa AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hanna Maria Ryttberg | Audit | 0 companies |
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Eva Cecilia Fråhn Juhlin | Board of Directors | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Johan Stefan Juhlin | Deputy Board Member | 0 companies |
| Nina Marika Wodzinski | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |